1 / 33

Local Anesthetic Systemic Toxicity Update Dr MUHAMMAD AMIM ANWAR LNH

This study discusses the diagnosis and management of local anesthetic systemic toxicity (LAST), a rare but potentially life-threatening adverse reaction to local anesthetic administration. The article highlights case studies and provides important information on the pharmacology, incidence, factors contributing to toxicity, and steps to manage LAST.

juliarogers
Download Presentation

Local Anesthetic Systemic Toxicity Update Dr MUHAMMAD AMIM ANWAR LNH

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. LocalAnestheticSystemicToxicity UpdateDr MUHAMMAD AMIM ANWARLNH

  2. Local Anaesthetic Systemic Toxicity • J ClinDiagn Res. 2015 Feb;9(2):UD03-4. doi: 10.7860/JCDR/2015/11104.5540. Epub 2015 Feb 1. • Local Anaesthetic Systemic Toxicity in a Patient under General Anaesthesia (GA): A Diagnostic Challenge. • Prakash R1, Gautam S1, Kumar S1, Singh R1 • A 25-year-old male patient undergoing laparotomy for acute duodenal perforation under general anaesthesia developed seizures after epidural administration of 0.5% bupivacaine. All other possible causes of seizures were ruled out. Seizures were controlled with antiepileptic drugs and patient recovered fully after withholding LA administration.

  3. Local Anaesthetic Systemic Toxicity • A healthy 18-yr-old male (weight 60 kg, height 167 cm), with a history of febrile convulsions in childhood, developed a grand mal convulsion 10 min after the second of two injections of ropivacaine 150 mg, both given incrementally 15 min apart (total 300 mg), for combined axillary/interscalene brachial plexus block. Treatment was with oxygen, lung ventilation, and i.v. midazolam, and the patient made a complete recovery. Arterial plasma ropivacaine concentration 2 min after the onset of convulsions was only 2.13 mg litre(-1), suggesting that this patient was particularly susceptible tolocal anaesthetic toxicity.

  4. Local Anaesthetic Systemic Toxicity

  5. Local Anaesthetic Systemic Toxicity

  6. Local Anaesthetic Systemic Toxicity

  7. Pharmacology • Local Anaesthetics are the agents that reversibly blocks the sodium channels preventing the further depolarization and impulse propagation is disrupted.

  8. Pharmacology • A local Anaesthetic consists of a lipophilic group attached to hydrophilic group by an ESTER or AMIDE CHAIN. • Esters: Cocaine, Procaine, Amethocaine, Benzocaine • Amides: Lignocaine, Prilocaine, Bupivacaine, Levobupivacaine

  9. Pharmacology • All the L A are weak bases with a pKa of 8-9 • Their penetration increases at alkaline pH and decreases at acidic pH of infected or inflammed area. • Esters are metabolised by plasma pseudocholinestrase. • Amides are metabolised by liver microsomal enzymes P450

  10. Maximum limit of safe dose • Esters : cocaine 3mg/kg, procaine 12mg/kg, chloroprocaine 12mg/kg, tetracaine 3mg/kg • Amides: prilocaine 8mg/kg, lignocaine 4-7mg/kg, bupivacaine 3mg/kg, ropivacaine 3mg/kg

  11. Incidence and prevalence • Interest in local anesthetic toxicity has had several peaks, including one that coincided with the initial awareness of local anesthetic toxicities after the introduction of cocaine in 1884, • another that followed the linking of fatalities to the use of bupivacaine and etidocaine in the 1970s, • and another after the introduction of ropivacaine and levobupivacaine in the late 1980s

  12. Incidence and prevalence • Injuries associated with regional anesthesia in the 1980s and 1990s: a closed claims analysis. • Lee LA1, Posner KL, Domino KB, Caplan RA, Cheney FW. • Half of the cases were block related • Of those half were due to cardiac arrest or unintentional intravascular administration • True incidence of LAST is difficult to measure • Reporting near misses is rare, reporting bias

  13. Factors contributing to toxicity • Site • Method of injection • Drug, dose, concentration and adjuncts • Patient : body weight, comorbids

  14. Drug Factors • Vasoactivity • Concentration • Dose • Route of administration • Rate of injection • Vascularity of the injection site • Presence of vasoconstrictors

  15. Adverse Drug Reactions 1) Side effects 2) Overdose reactions 3) Local toxic effects (most common) 4) Allergic reactions

  16. Detection of Toxicity

  17. Management • STOP : Stop injecting the Local Anaesthetic • HELP : Call for help • O2 : Maintain Airway Give 100% O2 Ensure adequate lung ventilation

  18. Management • MONITORS : Attach Monitors • IV ACCESS • CONTROL SEIZURES: Benzodiazepine, Thiopentone or Propofol

  19. Management • IN CASE OF CIRCULATORY ARREST • START CPR standard protocols • Manage Arrythmias ACLS protocols • Consider use of CPBypass if available

  20. Management • WITHOUT CIRCULATORY ARREST • Treat : Hypotension Bradycardia Tachyarrythmias

  21. Management • GIVE INTRAVENOUS LIPID EMULSION • Initial bolus dose 20% Lipid Emulsion 1.5ml/kg over 1 minute • Start an infusion of 20% Lipid Emulsion at 15ml/kg/hour (0.25 mL/kg/min for 30-60 minutes)

  22. Management • AFTER 5 MIN • Give a max of two repeat boluses in 5 min intervals: if cardiovascular stability has not been restored an adequate circulation deteriorates

  23. Management Continue infusion at same rate but bouble the rate to 30ml/kg/hr if cardiovascular stability has not been restored an adequate circulation deteriorates

  24. IMPORTANT • DO NOT EXCEED a MAXIMUM CUMULATIVE DOSE OF 12ml/kg

  25. INTRALIPID • LIPID SINK HYPOTHESIS : • Circulating lipid will absorb LA and shif the pharmacokinetics away from the tissue receptors. • METABOLIC HYPOTHESIS : • Lipids counteract LA inhibition of myocardial fatty acid metabolism thereby preserving ATP within heart. • Inotropic effect

  26. Practical guidelines • Preparation for LA Blocks • Consent • Explain • IV cannula • Emergency drugs and Equipment • Standard Monitors: ECG, Pulse oximeter, BP

  27. Practical guidelines

  28. Practical guidelines • Frequent aspiration • Test doses • Minimum sedation • Use of ultrasound

  29. Practical guidelines

  30. Practical guidelines

  31. Practical guidelines

  32. SUMMARY • L A Toxicity is a life threatening complication • Prompt detection and treatment is necessary for good patient outcome. • 2012 ASRA Guidelines include : monitoring, emergency equipment, modified ACLS protocols • Familiarity with LIPID RESCUE

  33. . • THANKS

More Related